$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the progressive cognitive impairment and memory decline. It processes the pathological features of the deposition of extracellular beta-amyloid (Aβ) plaques, intracellular neurofibrillary tangle (NFTs), and neuronal loss1. While these classic features have been the primary focus of therapeutic research, growing evidence underscores the critical role of decreased cerebral blood flow (CBF) in the pathogenesis and progression of AD2. CBF reduction occurs in the early stage of AD onset and is associated with the severity of cognitive dysfunction3. Therefore, the treatment strategy for improving cerebrovascular damage is an effective way to alleviate AD symptoms and improve the course of the disease.
Electroacupuncture (EA), a modern technique that integrates traditional acupuncture with electrical stimulation, has shown potential in improving cognitive function in AD. Studies suggest that EA may exert its beneficial effects through multiple mechanisms, such as reducing Aβ deposition, attenuating neuroinflammation, and promoting synaptic plasticity4. Notably, there is increasing speculation that the neuroprotective effects of EA may be closely linked to its ability to modulate CBF5. However, direct, real-time evidence demonstrating the impact of EA on cerebral hemodynamics in AD models remains limited. The lack of such evidence hinders a comprehensive understanding of how EA improves brain function.
Technological advancements in optical imaging have provided powerful tools for investigating cerebral hemodynamics. As a fast, wide-field optical technique, LSCI delivers high spatiotemporal resolution for visualizing volume-integrated tissue blood flow maps6, enabling real-time monitoring of electroacupuncture-induced perfusion dynamics. While skull exposure is required for optimal optical access, LSCI avoids invasive tissue penetration. LSCI was introduced in the 1990s and has been widely applied in neuroscience in the past few decades7. Like all imaging techniques, LSCI has inherent limitations: its optical penetration depth is constrained, favoring superficial cortical vasculature while limiting access to deep brain regions (e.g., hippocampus, basal ganglia), and it quantifies relative blood flow (perfusion units) rather than absolute CBF values, with accuracy subtly influenced by vascular morphology and tissue optical scattering8,9. However, these limitations do not undermine LSCI's utility but define its specialized application in real-time assessment of superficial cortical blood flow. For our study focusing on EA-induced cortical perfusion changes, LSCI provides reliable, actionable data. Specifically, we established a standardized LSCI protocol with targeted ROI delineation and optimized parameters to quantify CBF in APP/PS1 mice, complemented by Morris Water Maze tests to link cerebrovascular improvements with cognitive outcomes.